Showing results (141-150 of 157) with videos related to
Sort By:
Pageof 16
Epilepsia|May 31, 2013
Can structural or functional changes following traumatic brain injury in the rat predict epileptic outcome?Sandy R Shultz, Lisa Cardamone, Ying R Liu, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 15, 2011
Forum on aging and skeletal health: summary of the proceedings of an ASBMR workshopSundeep Khosla, Teresita M Bellido, Marc K Drezner, et al.Aging|January 8, 2020
Network analysis of human muscle adaptation to aging and contractionCraig R G Willis, Ryan M Ames, Colleen S Deane, et al.Journal of Psychosomatic Research|May 25, 2021
A multicenter survey of perioperative anxiety in China: Pre- and postoperative associationsXi-Rong Li, Wen-Hao Zhang, John P Williams, et al.Bioorganic & Medicinal Chemistry Letters|October 7, 2008
2,6-Diaryl-4-acylaminopyrimidines as potent and selective adenosine A(2A) antagonists with improved solubility and metabolic stabilityManisha Moorjani, Zhiyong Luo, Emily Lin, et al.Aging|April 19, 2019
The acute transcriptional response to resistance exercise: impact of age and contraction modeColleen S Deane, Ryan M Ames, Bethan E Phillips, et al.Function (Oxford, England)|July 10, 2024
Physiological Adaptations to Progressive Endurance Exercise Training in Adult and Aged Rats: Insights from the Molecular Transducers of Physical Activity Consortium (MoTrPAC)Simon Schenk, Tyler J Sagendorf, Gina M Many, et al.Journal of Medicinal Chemistry|August 5, 2005
Design and synthesis of tricyclic imidazo[4,5-b]pyridin-2-ones as corticotropin-releasing factor-1 antagonistsZhiqiang Guo, John E Tellew, Raymond S Gross, et al.Bioorganic & Medicinal Chemistry Letters|February 6, 2008
2,6-Diaryl-4-phenacylaminopyrimidines as potent and selective adenosine A(2A) antagonists with reduced hERG liabilityManisha Moorjani, Xiaohu Zhang, Yongsheng Chen, et al.Journal of Medicinal Chemistry|September 2, 2005
Design and synthesis of tricyclic corticotropin-releasing factor-1 antagonistsRaymond S Gross, Zhiqiang Guo, Brian Dyck, et al.Pageof 16